Eloxx Pharmaceuticals, Inc.

8-K Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Shareholder vote results May 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Director or officer change Aug 12, 2025 8-K Director or officer change Oct 17, 2024 8-K Entered a material agreement; Took on a direct financial obligation Jul 16, 2024 8-K Director or officer change Mar 29, 2024 8-K Entered a material agreement Mar 14, 2024 8-K Entered a material agreement; Unregistered sale of equity Jan 9, 2024 8-K Director or officer change Dec 28, 2023 8-K Entered a material agreement; Took on a direct financial obligation Dec 15, 2023 8-K Results of operations (earnings release) Nov 13, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Delisting notice or listing-rule failure Oct 16, 2023 8-K Entered a material agreement; Unregistered sale of equity Sep 20, 2023 8-K Other events Sep 18, 2023 8-K Director or officer change Sep 15, 2023 8-K Other events Sep 7, 2023 8-K Director or officer change Aug 29, 2023 8-K Regulation FD disclosure Aug 21, 2023 8-K Completed an acquisition or disposition Aug 14, 2023 10-Q Quarter ended 2023-06-30 Aug 11, 2023 8-K Other events Aug 3, 2023 8-K Other events Jul 13, 2023 8-K Shareholder vote results Jun 23, 2023 8-K Other events Jun 15, 2023 8-K Other events Jun 7, 2023 8-K Entered a material agreement; Terminated a material agreement; Other events May 24, 2023 8-K Results of operations (earnings release) May 16, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 8-K Delisting notice or listing-rule failure Apr 14, 2023 8-K Results of operations (earnings release) Apr 3, 2023 10-K Fiscal year ended 2022-12-31 Mar 31, 2023 8-K Entered a material agreement; Took on a direct financial obligation Mar 9, 2023 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results; Other events Dec 1, 2022 8-K Results of operations (earnings release) Nov 14, 2022 10-Q Quarter ended 2022-09-30 Nov 10, 2022 8-K Delisting notice or listing-rule failure Oct 14, 2022 8-K Regulation FD disclosure; Other events Sep 15, 2022